Objectives: Sentinel lymph node biopsy (SLNB) is widely used for staging breast cancer. SLNB accurately determines axillary lymph node status with a low false negative rate. There remains concern that omitting axillary dissection may lead to recurrence in the axilla, and impact long term survival. T
Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma
β Scribed by Jeanne S. Mandelblatt; Stephen B. Edge; Neal J. Meropol; Ruby Senie; Theodore Tsangaris; Luther Grey; Burt Peterson; Yi-Ting Hwang; Jane C. Weeks
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 110 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
There are few data on the long-term sequelae of axillary dissection among older breast carcinoma patients. we describe the impact of axillary dissection in a cohort of older women.
Methods:
A longitudinal cohort of 571 patients with stage 1 and 2 breast carcinoma, 67 years and older, diagnosed between 1995 and 1997 from 29 hospitals in five regions, and followed for 2 years. data were collected from patients and medical charts. the primary outcome was posttreatment quality of life. generalized estimation equation longitudinal modeling was used to evaluate the outcome, controlling for baseline function, comorbidity, age, clinical status, and other factors.
Results:
Sixty percent of women reported arm problems at some time in the 2 years after surgery. the cumulative risk of having arm problems 2 years posttreatment was three times higher (95% confidence interval 1.94-4.67) for women who underwent axillary surgery compared with women without axillary surgery, controlling for covariates. the effects of having axillary dissection and arthritis were multiplicative 2 years postsurgery. arm problems were, in turn, the primary determinate of lower physical and mental functioning (p = 0.0001 and 0.04, respectively), controlling for other factors. undergoing axillary dissection did not lessen fears about recurrence.
Conclusions:
Arm problems after axillary dissection have a consistent negative impact on quality of life, suggesting that the risks may outweigh the potential benefits in this population.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Axillary lymph node involvement (ALNI) remains the most accurate predictive factor for recurrence risk and survival in patients with invasive breast carcinoma (IBC) and is an essential element in therapeutic decisions. However, axillary dissection (AD) is responsible for
## Abstract ## BACKGROUND The role of axillary lymph node dissection (AxD) for patients with breast carcinoma who have clinically negative lymph nodes (cN0) and undergo breastβconserving therapy has been controversial. If patients do not undergo AxD, then it is uncertain whether specific lymph nod
## Abstract ## BACKGROUND Axillary dissection for the evaluation and treatment of patients with breast carcinoma often is not performed in older women. The objective of this study was to examine patient, clinical, and surgeon characteristics associated with the use of axillary dissection after bre
## Background: There are no data available from randomized controlled trials that compare the efficacy of sentinel lymph node (sln) biopsy with level i/ii axillary lymph node dissection (alnd) in patients with breast carcinoma. we performed a formal decision analysis to determine whether sln biopsy
## BACKGROUND. Evidence that avoiding axillary lymph node dissection (AxD) strikes an appropriate balance between morbidity and recurrence risk in patients with invasive breast carcinoma generally is anecdotal and without a formally quantified basis. The current study presents a decision analysis o